Activation of chaperone-mediated autophagy as a potential anticancer therapy

Lorena Galan-Acosta1, Hongguang Xia2, Junying Yuan2

  • 1a Division of Toxicology; Institute of Environmental Medicine; Karolinska Institutet ; Stockholm , Sweden.

Autophagy
|November 19, 2015
PubMed

Insights

Excessive activation of chaperone-mediated autophagy (CMA) eliminates cancer cells via metabolic catastrophe. This study reveals a novel strategy to degrade hexokinase 2 (HK2) in cancer cells, offering new therapeutic avenues.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway for specific proteins.
  • CMA defects are linked to neurodegenerative diseases due to protein aggregation.
  • The role of CMA in cancer remains poorly understood.

Purpose of the Study:

  • To investigate the role of CMA in cancer.
  • To identify a novel mechanism for cancer cell elimination via CMA.
  • To develop a strategy for targeting hexokinase 2 (HK2) degradation in cancer.

Main Methods:

  • Investigated CMA activity in cancer cells.
  • Explored the induction of metabolic catastrophe through excessive CMA activation.
  • Developed and tested a strategy to promote HK2 degradation via CMA.

Main Results:

  • Excessive CMA activation leads to cancer cell death through metabolic catastrophe.
  • A novel strategy effectively promotes the degradation of HK2 in cancer cells.
  • This approach offers a new perspective on CMA's role in oncology.

Conclusions:

  • Excessive CMA activation is a viable strategy for cancer cell elimination.
  • Targeting HK2 degradation through CMA presents a promising therapeutic approach for cancer treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K